WAT · NYQ · Healthcare
Waters Corporation
Also onShortfallConsensus DriftCrosscheck
Implied value per share
USD 333.08
Market price
USD 449.53
Implied upside
-25.9%
10-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case · Price 2026-11-02 · Accounts to 2025-12-31
Current EV/EBITDA of 44.6x sits outside a defensible 3-20x band, so the exit multiple is capped at 20.0x. A multiple that far out usually means EBITDA is the wrong denominator for this business.
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (USD). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 | FY32 | FY33 | FY34 | FY35 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | USD 4.7bn | USD 5.2bn | USD 5.7bn | USD 6.2bn | USD 6.7bn | USD 7.1bn | USD 7.5bn | USD 7.8bn | USD 8.1bn | USD 8.3bn | +6.4% |
| EBIT | USD 1.3bn | USD 1.5bn | USD 1.6bn | USD 1.7bn | USD 1.9bn | USD 2.0bn | USD 2.1bn | USD 2.2bn | USD 2.3bn | USD 2.3bn | +6.4% |
| NOPAT | USD 1.1bn | USD 1.2bn | USD 1.4bn | USD 1.5bn | USD 1.6bn | USD 1.7bn | USD 1.8bn | USD 1.8bn | USD 1.9bn | USD 2.0bn | +6.4% |
| Add depreciation & amortisation | USD 273.0m | USD 301.5m | USD 330.0m | USD 357.9m | USD 384.7m | USD 409.5m | USD 432.0m | USD 451.4m | USD 467.1m | USD 478.8m | +6.4% |
| Less capital expenditure | USD -237.2m | USD -267.8m | USD -299.4m | USD -331.5m | USD -363.6m | USD -395.0m | USD -424.9m | USD -452.6m | USD -477.3m | USD -498.4m | +8.6% |
| Capex, % of revenue | 5.0% | 5.1% | 5.2% | 5.3% | 5.4% | 5.5% | 5.7% | 5.8% | 5.9% | 6.0% | - |
| Less increase in working capital | USD -600.5m | USD -188.2m | USD -188.1m | USD -184.2m | USD -176.3m | USD -164.3m | USD -148.1m | USD -127.9m | USD -104.0m | USD -77.1m | -20.4% |
| Free cashflow to firm | USD 553.3m | USD 1.1bn | USD 1.2bn | USD 1.3bn | USD 1.4bn | USD 1.5bn | USD 1.6bn | USD 1.7bn | USD 1.8bn | USD 1.9bn | +14.5% |
| Discount factor | 0.9562 | 0.8742 | 0.7992 | 0.7307 | 0.6681 | 0.6108 | 0.5584 | 0.5105 | 0.4668 | 0.4267 | - |
| Present value | USD 529.0m | USD 944.4m | USD 954.3m | USD 955.7m | USD 948.6m | USD 932.9m | USD 909.1m | USD 877.7m | USD 839.6m | USD 795.5m | - |
| Present Value Of The Forecast | USD 8.7bn | ||||||||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 4.89% | US 10-year Treasury (^TNX), 2026-11-02 |
| Equity risk premium | 4.23% | Damodaran, January 2026 |
| Beta | 1.099 | Reported 1.148, pulled toward 1.0 (Blume) |
| Cost of equity | 9.54% | Risk-free + beta x equity risk premium |
| Cost of debt | 5.29% | Risk-free + 40bp, the spread for a AAA rating at 11.5x interest cover. Book interest / average debt was lower, at 4.4%. |
| Market capitalisation | USD 44.1bn | 96.7% of capital |
| Total debt | USD 1.5bn | 3.3% of capital, book value as a proxy |
| Tax rate | 15.2% | Effective, capped at statutory |
| WACC | 9.38% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
58% of EV
- Forecast FCFF, final year
- USD 1.9bn
- Capex at depreciation, working capital in reinvestment
- USD 2.2bn
- Less reinvestment at g/ROIC (12.4% of NOPAT)
- USD -269.2m
- Capitalised
- USD 1.9bn
- ROIC (reported)
- 20.2%
- Terminal value, undiscounted
- USD 28.4bn
- Terminal value, discounted
- USD 12.1bn
- Enterprise value
- USD 20.8bn
- Less net debt
- USD 903.3m
- Equity value
- USD 19.9bn
Exit at 20.0x EBITDA
73% of EV
- Terminal value, undiscounted
- USD 55.8bn
- Terminal value, discounted
- USD 23.8bn
- Enterprise value
- USD 32.5bn
- Less net debt
- USD 903.3m
- Equity value
- USD 31.6bn
Spread between methods: 46%.
Sensitivity
Value per share (USD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 7.38% | 445.53 | 463.43 | 485.42 | 512.89 | 547.97 |
| 8.38% | 373.45 | 383.77 | 396.17 | 411.24 | 429.78 |
| 9.38% | 319.93 | 325.94 | 333.08 | 341.63 | 351.94 |
| 10.38% | 278.70 | 282.11 | 286.18 | 291.03 | 296.84 |
| 11.38% | 246.00 | 247.80 | 249.99 | 252.63 | 255.81 |
Outlined: this model. Green text: above today's price of 449.53. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Actual | Model | Implied | Gap |
|---|---|---|---|---|
| Revenue growth, a year | 2.1% | 10.2% | 14.1% | |
| EBIT margin | 29.7% | 27.8% | 37.2% | |
| Discount rate | - | 9.4% | 7.7% |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.